Xiaojiaoyang Li

MedicinePharmacology, Toxicology and PharmaceuticsBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead”.

Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead

Acta Pharmaceutica Sinica B(2023)10.1016/j.apsb.2023.10.023

N/A

0DataRank · unranked

49 citations

Yajing Li, Qi Zheng, Mingning Ding, Huiping Zhou, Xiaojiaoyang Li +1 more